Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06752460
NA

Evaluation of the EF192B Protection Versus No Treatment

Sponsor: Eurofarma Laboratorios S.A.

View on ClinicalTrials.gov

Summary

This study was designed with the objective of evaluating the protection potential provided by the experimental product EF192B by evaluating its barrier formation capacity. Once its ability to form a barrier is confirmed, EF192B ability to protect against small skin injuries, such as small cuts, bruises, blisters and cracks is confirmed. The barrier formation also guarantees protection against the formation of calluses.

Official title: Randomized, Open Clinical Study to Evaluate the Protective Potential of EF192B Versus No Treatment

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2025-08-31

Completion Date

2025-10-31

Last Updated

2024-12-30

Healthy Volunteers

Yes

Interventions

DEVICE

EF192B

EF192B will be applied after the tape strriping procedure and will be reapplied after 12 hours.

Locations (1)

Eurofarma Laboratórios S.A

Itapevi, São Paulo, Brazil